Literature DB >> 28203777

2017 Infectious Diseases Society of America's Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis.

Allan R Tunkel1, Rodrigo Hasbun2, Adarsh Bhimraj3, Karin Byers4, Sheldon L Kaplan5, W Michael Scheld6, Diederik van de Beek7, Thomas P Bleck8, Hugh J L Garton9, Joseph R Zunt10.   

Abstract

The Infectious Diseases Society of America (IDSA) Standards and Practice Guidelines Committee collaborated with partner organizations to convene a panel of 10 experts on healthcare-associated ventriculitis and meningitis. The panel represented pediatric and adult specialists in the field of infectious diseases and represented other organizations whose members care for patients with healthcare-associated ventriculitis and meningitis (American Academy of Neurology, American Association of Neurological Surgeons, and Neurocritical Care Society). The panel reviewed articles based on literature reviews, review articles and book chapters, evaluated the evidence and drafted recommendations. Questions were reviewed and approved by panel members. Subcategories were included for some questions based on specific populations of patients who may develop healthcare-associated ventriculitis and meningitis after the following procedures or situations: cerebrospinal fluid shunts, cerebrospinal fluid drains, implantation of intrathecal infusion pumps, implantation of deep brain stimulation hardware, and general neurosurgery and head trauma. Recommendations were followed by the strength of the recommendation and the quality of the evidence supporting the recommendation. Many recommendations, however, were based on expert opinion because rigorous clinical data are not available. These guidelines represent a practical and useful approach to assist practicing clinicians in the management of these challenging infections.
© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  central nervous system infections.; cerebrospinal fluid drains; cerebrospinal fluid shunts; ventriculitis; meningitis

Year:  2017        PMID: 28203777      PMCID: PMC5848239          DOI: 10.1093/cid/ciw861

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  207 in total

1.  Healthcare savings associated with reduced infection rates using antimicrobial suture wound closure for cerebrospinal fluid shunt procedures.

Authors:  Jonathan Stone; Thomas J Gruber; Curtis J Rozzelle
Journal:  Pediatr Neurosurg       Date:  2010-05-05       Impact factor: 1.162

Review 2.  Improving the role of intraventricular antimicrobial agents in the management of meningitis.

Authors:  Wendy C Ziai; John J Lewin
Journal:  Curr Opin Neurol       Date:  2009-06       Impact factor: 5.710

3.  Culture-negative Candida meningitis diagnosed by detection of Candida mannan antigen in CSF.

Authors:  J Matthijs Biesbroek; Frans M Verduyn Lunel; J Jolijn Kragt; G Johan Amelink; Catherina J M Frijns
Journal:  Neurology       Date:  2013-09-25       Impact factor: 9.910

4.  Characteristics of infections associated with external ventricular drains of cerebrospinal fluid.

Authors:  Laura N Walti; Anna Conen; Julia Coward; Gregory F Jost; Andrej Trampuz
Journal:  J Infect       Date:  2013-01-09       Impact factor: 6.072

5.  Results of trimethoprim-sulfamethoxazole prophylaxis in ventriculostomy and shunting procedures. A double-blind randomized trial.

Authors:  G C Blomstedt
Journal:  J Neurosurg       Date:  1985-05       Impact factor: 5.115

6.  Intraventricular daptomycin and intravenous linezolid for the treatment of external ventricular-drain-associated ventriculitis due to vancomycin-resistant Enterococcus faecium.

Authors:  Scott W Mueller; Tyree H Kiser; Tracey A Anderson; Robert T Neumann
Journal:  Ann Pharmacother       Date:  2012-12-11       Impact factor: 3.154

7.  Gram-negative meningitis and infections in individuals treated with intrathecal baclofen for spasticity: a retrospective study.

Authors:  Colleen A Wunderlich; Linda E Krach
Journal:  Dev Med Child Neurol       Date:  2006-06       Impact factor: 5.449

8.  CSF shunt infections in children.

Authors:  U Kontny; B Höfling; P Gutjahr; D Voth; M Schwarz; H J Schmitt
Journal:  Infection       Date:  1993 Mar-Apr       Impact factor: 3.553

9.  Use of ventricular cerebrospinal fluid lactate measurement to diagnose cerebrospinal fluid infection in patients with intraventricular haemorrhage.

Authors:  G K Wong; W S Poon; M Ip
Journal:  J Clin Neurosci       Date:  2008-03-14       Impact factor: 1.961

10.  Early diagnosis of external ventricular drainage infection: results of a prospective study.

Authors:  W Pfisterer; M Mühlbauer; T Czech; A Reinprecht
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-07       Impact factor: 10.154

View more
  132 in total

1.  A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiology.

Authors:  J Michael Miller; Matthew J Binnicker; Sheldon Campbell; Karen C Carroll; Kimberle C Chapin; Peter H Gilligan; Mark D Gonzalez; Robert C Jerris; Sue C Kehl; Robin Patel; Bobbi S Pritt; Sandra S Richter; Barbara Robinson-Dunn; Joseph D Schwartzman; James W Snyder; Sam Telford; Elitza S Theel; Richard B Thomson; Melvin P Weinstein; Joseph D Yao
Journal:  Clin Infect Dis       Date:  2018-08-31       Impact factor: 9.079

2.  Cutibacterium acnes: the Urgent Need To Identify Diagnosis Markers.

Authors:  C Mongaret; F Velard; F Reffuveille
Journal:  Infect Immun       Date:  2021-03-17       Impact factor: 3.441

Review 3.  Infections in Neurocritical Care.

Authors:  John C O'Horo; Priya Sampathkumar
Journal:  Neurocrit Care       Date:  2017-12       Impact factor: 3.210

4.  Understanding central nervous system efficacy of antimicrobials.

Authors:  Pierre Tattevin; Tom Solomon; Matthijs C Brouwer
Journal:  Intensive Care Med       Date:  2018-06-23       Impact factor: 17.440

5.  Case Report of Successful Treatment of Extensively Drug-Resistant Acinetobacter baumannii Ventriculitis with Intravenous plus Intraventricular Tigecycline.

Authors:  Yan Liu; Zenghui Pu; Maomao Zhao
Journal:  Antimicrob Agents Chemother       Date:  2018-10-24       Impact factor: 5.191

Review 6.  Diagnostic Approach to Health Care- and Device-Associated Central Nervous System Infections.

Authors:  Ryan M Martin; Lara L Zimmermann; Mindy Huynh; Christopher R Polage
Journal:  J Clin Microbiol       Date:  2018-10-25       Impact factor: 5.948

7.  Reinfection after treatment of first cerebrospinal fluid shunt infection: a prospective observational cohort study.

Authors:  Tamara D Simon; Matthew P Kronman; Kathryn B Whitlock; Nancy E Gove; Nicole Mayer-Hamblett; Samuel R Browd; D Douglas Cochrane; Richard Holubkov; Abhaya V Kulkarni; Marcie Langley; David D Limbrick; Thomas G Luerssen; W Jerry Oakes; Jay Riva-Cambrin; Curtis Rozzelle; Chevis Shannon; Mandeep Tamber; John C Wellons; William E Whitehead; John R W Kestle
Journal:  J Neurosurg Pediatr       Date:  2018-02-02       Impact factor: 2.375

8.  Relationship of causative organism and time to infection among children with cerebrospinal fluid shunt infection.

Authors:  Matthew R Test; Kathryn B Whitlock; Marcie Langley; Jay Riva-Cambrin; John R W Kestle; Tamara D Simon
Journal:  J Neurosurg Pediatr       Date:  2019-05-03       Impact factor: 2.375

Review 9.  Antibiotic Distribution into Cerebrospinal Fluid: Can Dosing Safely Account for Drug and Disease Factors in the Treatment of Ventriculostomy-Associated Infections?

Authors:  Nilesh Kumta; Jason A Roberts; Jeffrey Lipman; Menino Osbert Cotta
Journal:  Clin Pharmacokinet       Date:  2018-04       Impact factor: 6.447

Review 10.  Infectious Disease Complications in Patients with Cancer.

Authors:  Susan K Seo; Catherine Liu; Sanjeet S Dadwal
Journal:  Crit Care Clin       Date:  2020-11-01       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.